Want to join the conversation?
$VRTX has exclusively licensed VX-210 to treat acute spinal cord injury from BioAxone BioSciences. VX-210 is designed to inhibit protein known as Rho that blocks neural regeneration after injury. $VRTX will start Phase 2b/3 clinical trial in 1H16 to evaluate efficacy and safety of VX-210 in patients with certain acute cervical spinal cord injuries.
$BA won a $22 billion deal from SpiceJet, their largest order from an Indian airline.
$FB stock remained in the green territory after Raymond James upgraded shares to strong buy from outperform, on expectations that overall 4Q16 ad spending was strong.
$ARRY Good day for the stock, jumped 7%. Great gains !
2017 was supposed to be another record year for automotive industry. Still, $F Ford thinks its profit will dip in 2017..!!
$KKR to buy Hitachi’s power tool unit Hitachi Koki for $1.3 billion. Looks like KKR & Co is going strong in Japan! Remember when it bought Calsonic Kansei a while back?